Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
BMC Cancer|February 29, 2016
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark surveyRuben Mesa, Carole B Miller, Maureen Thyne, et al.
Therapeutic Advances in Hematology|February 21, 2024
Interferons in the treatment of myeloproliferative neoplasmsPankit Vachhani, John Mascarenhas, Prithviraj Bose, et al.
Haematologica|November 20, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a reviewPankit Vachhani, Ruben Mesa, John Mascarenhas, et al.
Cancer Medicine|September 25, 2020
Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex conditionLeslie Padrnos, Robyn Scherber, Holly Geyer, et al.
Leukemia Research|June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional databaseDouglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.
Leukemia Research|June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center databaseNoa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.
Hematological Oncology|January 18, 2025
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative NeoplasmsTariq I Mughal, John Mascarenhas, Raajit K Rampal, et al.
Leukemia & Lymphoma|June 2, 2024
Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasmsBlake Langlais, Amylou C Dueck, Heidi E Kosiorek, et al.
Haematologica|March 16, 2012
Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsKrisstina Gowin, Prakash Thapaliya, Jan Samuelson, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
Pageof 18